HK1199879A1 - Pde9 inhibitors with imidazo triazinone backbone pde9 - Google Patents

Pde9 inhibitors with imidazo triazinone backbone pde9

Info

Publication number
HK1199879A1
HK1199879A1 HK15100346.4A HK15100346A HK1199879A1 HK 1199879 A1 HK1199879 A1 HK 1199879A1 HK 15100346 A HK15100346 A HK 15100346A HK 1199879 A1 HK1199879 A1 HK 1199879A1
Authority
HK
Hong Kong
Prior art keywords
pde9
inhibitors
backbone
imidazo
imidazo triazinone
Prior art date
Application number
HK15100346.4A
Other languages
English (en)
Chinese (zh)
Inventor
Niels Svenstrup
Klaus Baek Simonsen
Lars Kyhn Rasmussen
Karsten Juhl
Morten Langgard
Kate Wen
Yazhou Wang
Original Assignee
Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck As filed Critical Lundbeck As
Publication of HK1199879A1 publication Critical patent/HK1199879A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15100346.4A 2012-01-26 2015-01-13 Pde9 inhibitors with imidazo triazinone backbone pde9 HK1199879A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2012070718 2012-01-26
CN2012080208 2012-08-16
PCT/EP2013/051451 WO2013110768A1 (en) 2012-01-26 2013-01-25 Pde9 inhibitors with imidazo triazinone backbone

Publications (1)

Publication Number Publication Date
HK1199879A1 true HK1199879A1 (en) 2015-07-24

Family

ID=47603775

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100346.4A HK1199879A1 (en) 2012-01-26 2015-01-13 Pde9 inhibitors with imidazo triazinone backbone pde9

Country Status (15)

Country Link
US (3) US9434733B2 (xx)
EP (2) EP3178820B1 (xx)
CN (2) CN107082783B (xx)
AP (1) AP2014007820A0 (xx)
AU (2) AU2013213603B2 (xx)
BR (1) BR112014018199A8 (xx)
CO (1) CO7020913A2 (xx)
CR (1) CR20140361A (xx)
DO (1) DOP2014000175A (xx)
EC (1) ECSP14015609A (xx)
HK (1) HK1199879A1 (xx)
MX (1) MX351582B (xx)
PH (1) PH12014501695B1 (xx)
SG (1) SG11201403909RA (xx)
WO (1) WO2013110768A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI541244B (zh) 2010-09-20 2016-07-11 福倫製藥股份有限公司 咪唑三酮化合物
US9561338B2 (en) 2010-10-08 2017-02-07 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
MA37958B1 (fr) 2011-10-10 2018-10-31 H Lundbeck As Pde9i ayant un squelette imidazo pyrazinone
EP3178820B1 (en) 2012-01-26 2017-12-20 H. Lundbeck A/S Pde9- inhibitors with imidazo triazinone backbone
WO2013142269A1 (en) 2012-03-19 2013-09-26 Envivo Pharmaceuticals, Inc. Imidazotriazinone compounds
KR20160007347A (ko) 2014-07-11 2016-01-20 에스티팜 주식회사 신규한 이미다조트리아지논 또는 이미다조피라지논 유도체, 및 이들의 용도
WO2016006975A2 (en) * 2014-07-11 2016-01-14 St Pharm Co., Ltd. Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
TW201629064A (zh) 2014-10-10 2016-08-16 H 朗德貝克公司 作爲pde1抑制劑之三唑並吡酮
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
WO2017000276A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
CN112010861A (zh) 2015-07-07 2020-12-01 H.隆德贝克有限公司 用于治疗外周疾病的具有咪唑并三嗪酮骨架和咪唑并吡嗪酮骨架的pde9抑制剂
CN105669680B (zh) * 2016-03-24 2018-02-23 南京药捷安康生物科技有限公司 吡咯并[2,1‑f][1,2,4]三嗪‑4(1H)‑酮衍生物类PDE9A抑制剂
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商H 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
EP3481398A1 (en) * 2016-07-06 2019-05-15 Imara, Inc. Pde9 inhibitors for treatment of peripheral diseases
EP3529250B1 (en) 2016-10-18 2023-12-06 H. Lundbeck A/S Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as pde1 inhibitors
CA3041595A1 (en) 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising administration of imidazopyrazinones
SI3532064T1 (sl) 2016-10-28 2020-10-30 H. Lundbeck A/S Kombinirana zdravljenja, ki obsegajo imidazopirazinone za zdravljenje psihiatričnih in/ali kognitivnih motenj
DK3541784T3 (en) * 2016-11-18 2023-10-23 Integrative Res Laboratories Sweden Ab Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
MX2019010003A (es) 2017-02-23 2019-12-16 Boehringer Ingelheim Int Nuevo uso medico del compuesto iii.
PL3630772T3 (pl) * 2017-05-26 2024-08-05 Cardurion Pharmaceuticals, Inc. Sposoby wytwarzania inhibitora pde9
CN110003213B (zh) * 2018-01-04 2021-10-08 南京农业大学 苯并咪唑并三嗪酮类化合物、制备方法及应用
KR20200106513A (ko) 2018-01-05 2020-09-14 다이서나 파마수이티컬, 인크. 면역요법을 강화시키기 위하여 베타-카테닌 및 ido 발현의 감소
BR112020024019A2 (pt) 2018-05-25 2021-02-23 Imara Inc. monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona
TW202108585A (zh) * 2019-05-07 2021-03-01 美商伊馬拉公司 用於治療地中海型貧血之pde9抑制劑
CN113072556B (zh) * 2021-03-30 2022-02-01 牡丹江医学院 一种用于治疗胶质瘤的药物及其制备方法
WO2024107445A1 (en) * 2022-11-15 2024-05-23 Freedom Biosciences, Inc. Enhancement of the efficacy of serotonergic psychedelic drugs in the treatment or prevention of certain neuropsychiatric disorders through inhibition of type-9 phosphodiesterases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230154B1 (hu) 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
CN1344268A (zh) 1999-01-20 2002-04-10 德雷斯顿药品工厂有限公司 咪唑[1,5-a]吡啶并[3,2-e]吡嗪酮作为药物的应用
EP1444009A1 (en) 2001-11-02 2004-08-11 Pfizer Products Inc. Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
HN2002000317A (es) 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
GB2388111A (en) 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
US6684626B1 (en) 2002-07-30 2004-02-03 General Electric Company Aircraft gas turbine engine with control vanes for counter rotating low pressure turbines
US20040220186A1 (en) 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
WO2005041972A1 (en) 2003-10-31 2005-05-12 Pfizer Products Inc. Phosphodiesterase 9 inhibition as treatment for obesity-related conditions
AR053090A1 (es) 2004-07-20 2007-04-25 Osi Pharm Inc Imidazotriazinas como inhibidores de proteina quinasas y su uso para la preparacion de medicamentos
TW200815436A (en) 2006-05-30 2008-04-01 Elbion Ag 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
US8299080B2 (en) 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
BRPI0811280B8 (pt) * 2007-05-11 2021-05-25 Pfizer compostos amino-heterocíclicos, composição farmacêutica que os compreende e usos dos referidos compostos
DE102007032349A1 (de) 2007-07-11 2009-01-15 Bayer Healthcare Ag Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
EP2231646A1 (en) 2007-12-10 2010-09-29 GlaxoSmithKline LLC Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
TWI404721B (zh) 2009-01-26 2013-08-11 Pfizer 胺基-雜環化合物
EP2456311A4 (en) 2009-07-24 2013-01-23 Concert Pharmaceuticals Inc SUBSTITUTED IMIDASOTRIAZINES
WO2011028820A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
TWI541244B (zh) 2010-09-20 2016-07-11 福倫製藥股份有限公司 咪唑三酮化合物
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
EP3178820B1 (en) * 2012-01-26 2017-12-20 H. Lundbeck A/S Pde9- inhibitors with imidazo triazinone backbone

Also Published As

Publication number Publication date
US20170081333A1 (en) 2017-03-23
CN104093720B (zh) 2017-04-12
US9850249B2 (en) 2017-12-26
CN104093720A (zh) 2014-10-08
US9434733B2 (en) 2016-09-06
AU2013213603B2 (en) 2017-02-02
AU2017200886A1 (en) 2017-03-02
SG11201403909RA (en) 2014-10-30
BR112014018199A8 (pt) 2021-03-02
EP2807163B1 (en) 2017-03-22
AU2013213603A1 (en) 2014-07-24
CN107082783B (zh) 2019-03-22
CR20140361A (es) 2014-11-11
MX351582B (es) 2017-10-20
ECSP14015609A (es) 2015-12-31
WO2013110768A1 (en) 2013-08-01
CN107082783A (zh) 2017-08-22
PH12014501695A1 (en) 2014-10-20
US20150045348A1 (en) 2015-02-12
EP2807163A1 (en) 2014-12-03
EP3178820A1 (en) 2017-06-14
MX2014008912A (es) 2014-08-26
US9533992B2 (en) 2017-01-03
US20160213674A1 (en) 2016-07-28
EP3178820B1 (en) 2017-12-20
AP2014007820A0 (en) 2014-07-31
PH12014501695B1 (en) 2014-10-20
CO7020913A2 (es) 2014-08-11
AU2017200886B2 (en) 2018-01-18
DOP2014000175A (es) 2014-08-31

Similar Documents

Publication Publication Date Title
HK1199879A1 (en) Pde9 inhibitors with imidazo triazinone backbone pde9
IL253448A0 (en) Pde91 is an imidazo- pyrazinone backbone
HRP20181041T1 (hr) Pirazolopirimidinski spojevi
HK1208444A1 (en) Pyrrolobenzodiazepines
HK1208217A1 (en) Pyrrolobenzodiazepines
HK1206795A1 (en) Rapid aneuploidy detection
EP2865097A4 (en) RECEIVER WITH HIGH SPECTRAL EFFICIENCY
HK1211029A1 (en) Pyrazolopyrimidine compounds
EP2934535A4 (en) SUBSTITUTED PYRROLOPYRIMIDINES AS HDM2 INHIBITORS
IL230997A0 (en) 10pde pyrimidine inhibitors
EP2785183A4 (en) TRIAZOLOPYRIDINONE PDE10 INHIBITORS
GB2499421B (en) Ramp
IL235829A0 (en) Triazolo compounds as pde10 inhibitors
EP2621926A4 (en) PDE10 PYRAZOLPYRIMIDININHIBITOREN
GB201215033D0 (en) Diazepinone derivatives
GB201219935D0 (en) Belt it
EP2922823A4 (en) PDE10 PYRIMIDININHIBITOREN
HK1204617A1 (en) Triazolo compounds as pde10 inhibitors pde10
EP2919783A4 (en) CYCLOPROPYLIMIDAZOPYRIDINE USEFUL AS PDE10 INHIBITOR
GB201218984D0 (en) Receiver
GB201214593D0 (en) Spirit level clamp
HU4129U (en) Multi-purpose lighting device
AU2012104V (en) Proquest M703 Mandevilla hybrid
GB201204319D0 (en) Floor insert